RxSight logo

RxSightNASDAQ: RXST

Profile

Sector:

Healthcare

Country:

United States

IPO:

30 July 2021

Next earnings report:

07 November 2024

Last dividends:

N/A

Next dividends:

N/A
$2.13 B
-16%vs. 3y high
81%vs. sector
-vs. 3y high
-vs. sector
-50%vs. 3y high
89%vs. sector
-26%vs. 3y high
83%vs. sector

Price

after hours | Fri, 01 Nov 2024 21:33:44 GMT
$53.65+$4.04(+8.14%)

Dividend

No data over the past 3 years
$34.89 M$35.06 M
$34.89 M-$6.08 M

Analysts recommendations

Institutional Ownership

RXST Latest News

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
globenewswire.com22 August 2024 Sentiment: POSITIVE

ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced its plans to participate in two upcoming healthcare conferences in September.

Investing In The Future Of Cataract Surgery: The RxSight Advantage
seekingalpha.com13 August 2024 Sentiment: POSITIVE

RxSight, Inc. is transforming cataract surgery with the Light Adjustable Lens system, offering postoperative customization for superior vision outcomes. The global cataract devices market is rapidly expanding, with RxSight well-positioned to capitalize on the growing demand for premium IOLs. Impressive financial performance in Q2 2024, with significant revenue growth, gross profit margin improvement, and raised full-year revenue guidance.

Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect?
zacks.com12 August 2024 Sentiment: POSITIVE

The mean of analysts' price targets for RxSight (RXST) points to a 27.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2
zacks.com05 August 2024 Sentiment: POSITIVE

RxSight, Inc. (RXST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.40 per share a year ago.

The 3 Best Med Tech Stocks to Buy Now
investorplace.com05 August 2024 Sentiment: POSITIVE

According to the Advanced Medical Technology Association, med tech is defined as “companies that develop, manufacture, and distribute the technologies, devices, equipment, diagnostic tests, and health information systems.” The organization reports that these firms favorably change health care with “earlier disease detection, less-invasive procedures, and more effective treatments.

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
globenewswire.com22 July 2024 Sentiment: POSITIVE

ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second quarter of 2024 after the market close on Monday, August 5, 2024. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

RxSight, Inc. To Participate in the Truist Securities Medtech Conference
globenewswire.com05 June 2024 Sentiment: POSITIVE

ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference.

What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?
zacks.com28 May 2024 Sentiment: POSITIVE

Does RxSight, Inc. (RXST) have what it takes to be a top stock pick for momentum investors? Let's find out.

RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript
Seeking Alpha28 February 2024 Sentiment: POSITIVE

RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript

RxSight, Inc. (RXST) Q3 2023 Earnings Call Transcript
Seeking Alpha12 November 2023 Sentiment: POSITIVE

RxSight, Inc. (NASDAQ:RXST ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Alex Huang - Director, Investor Relations Ron Kurtz - President and Chief Executive Officer Shelley Thunen - Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Larry Biegelsen - Wells Fargo Joseph Conway - Needham & Co Rohin Patel - JPMorgan Steven Lichtman - Oppenheimer Operator Good day, and thank you for standing by. Welcome to the RxSight Third Quarter 2023 Earnings Call.

What type of business is RxSight?

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

What sector is RxSight in?

RxSight is in the Healthcare sector

What industry is RxSight in?

RxSight is in the Medical Devices industry

What country is RxSight from?

RxSight is headquartered in United States

When did RxSight go public?

RxSight initial public offering (IPO) was on 30 July 2021

What is RxSight website?

https://www.rxsight.com

Is RxSight in the S&P 500?

No, RxSight is not included in the S&P 500 index

Is RxSight in the NASDAQ 100?

No, RxSight is not included in the NASDAQ 100 index

Is RxSight in the Dow Jones?

No, RxSight is not included in the Dow Jones index

When was RxSight the previous earnings report?

No data

When does RxSight earnings report?

The next expected earnings date for RxSight is 07 November 2024